DFTX: Definium Therapeutics, Inc.
Performance
DFTX +202.48%
Watchlist
Select an item
Summary
DFTX at a glance
DFTX returned +202.48% over the past year and -0.26% a year over five years. Its worst drop in that year was -37.34%, smaller than 42% of stocks on Redstone, and its Sharpe ratio of 1.73 beats 96% of stocks on Redstone. It pays no dividends.
Current Drawdown
-26.96%
Rolling Volatility
75.13%
Actions
Metrics
Risk Indicators
Alpha123.34%
Beta1.15x
Sharpe1.73
Sortino3.61
Omega1.42
Calmar5.42
Martin10.67
Profile
About DFTX
Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction.
- Sector
- Health Care
- Industry
- Medicinal Chemicals & Botanical Products
- Market cap
- $4.8B
- Listed
- Mar 2020
- Employees
- 106
- Headquarters
- New York, NY
- Website
- definiumtx.com
Comparisons